drugset / Trial / NCT01162889

Study To Assess The Safety And Tolerability Of Increasing Single Doses Of ATR-107 (PF-05230900) In Healthy People

NCT01162889 ↗

Phase 1 Terminated 70 enrolled Pfizer
RandomizedParallel-groupDouble-blind

Summary

This is a "first in human" study to determine the safety and tolerability of the drug after single doses. Nine doses of increasing strength will be injected or infused (given into a vein) to 9 different groups of people. One third of the participants will be given an injection or infusion of placebo (sugar water). All participants will be healthy people.

Timeline

Start
2010-06
Primary completion
2012-01
Completion
2012-01

Outcome

Outcome not reported

Stopped: “See termination reason in detailed description.”

Drugs

EvaluationDrugModalityDoseRoute
Subject ATR-107 Unknown — Subcutaneous

Indications

No indication recorded.